221 related articles for article (PubMed ID: 32559641)
1. MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction.
Di Mauro I; Mescam-Mancini L; Chetaille B; Lae M; Pierron G; Dadone-Montaudie B; Bazin A; Bouvier C; Michiels JF; Pedeutour F
Neoplasia; 2020 Aug; 22(8):311-321. PubMed ID: 32559641
[TBL] [Abstract][Full Text] [Related]
2. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
[TBL] [Abstract][Full Text] [Related]
3. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
[TBL] [Abstract][Full Text] [Related]
4. Synovial sarcoma showing loss of a green signal in SS18 fluorescence in situ hybridization: a clinicopathological and molecular study of 12 cases.
Jiang D; Peng R; Yan X; Chen M; Lan T; Chen H; Zhang Z; Jing W; Jiang L; Ma L; Zhang H
Virchows Arch; 2017 Dec; 471(6):799-807. PubMed ID: 28761985
[TBL] [Abstract][Full Text] [Related]
5. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.
Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M
Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541
[TBL] [Abstract][Full Text] [Related]
6. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
[TBL] [Abstract][Full Text] [Related]
7. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
[TBL] [Abstract][Full Text] [Related]
8. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis.
Lasota J; Chłopek M; Kaczorowski M; Natálie K; Ryś J; Kopczyński J; Sulaieva O; Michal M; Kruczak A; Harazin-Lechowska A; Szczepaniak M; Koshyk O; Hałoń A; Czapiewski P; Abdullaev Z; Kowalik A; Aldape KD; Michal M; Miettinen M
Am J Surg Pathol; 2024 Jan; 48(1):97-105. PubMed ID: 37899499
[TBL] [Abstract][Full Text] [Related]
9. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
[TBL] [Abstract][Full Text] [Related]
10. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
[TBL] [Abstract][Full Text] [Related]
11. BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall.
Kao YC; Sung YS; Zhang L; Kenan S; Singer S; Tap WD; Swanson D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2017 Apr; 56(4):296-302. PubMed ID: 27914109
[TBL] [Abstract][Full Text] [Related]
12. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
13. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma.
Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F
Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645
[TBL] [Abstract][Full Text] [Related]
14. Histology and grading are important prognostic factors in synovial sarcoma.
Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel SSX1 fusions in synovial sarcoma.
Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T
Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309
[TBL] [Abstract][Full Text] [Related]
16. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.
Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M
PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893
[TBL] [Abstract][Full Text] [Related]
17. [Expression of SS18-SSX fusion-specific antibody and SSX C-terminal antibody in synovial sarcoma and its diagnostic value].
Wang X; Cheng K; Wu N; Li R; Chen H; Ma HH; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):740-744. PubMed ID: 34405607
[No Abstract] [Full Text] [Related]
18. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
[TBL] [Abstract][Full Text] [Related]
19. The clinical implication of SS18-SSX fusion gene in synovial sarcoma.
Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y
Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186
[TBL] [Abstract][Full Text] [Related]
20. Vanished MDM2 amplification in multiple recurrences of an irradiated poorly differentiated sarcoma with amplified TRIO::TERT fusion gene.
Goffinet S; Di Mauro I; Doyen J; Boyer J; Birtwisle-Peyrottes I; Keslair F; Pedeutour F; Dadone-Montaudie B
Genes Chromosomes Cancer; 2023 Jun; 62(6):342-352. PubMed ID: 36916207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
